Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$272M |
| 2 |
Chevron
CVX
|
+$206M |
| 3 |
Tesla
TSLA
|
+$153M |
| 4 |
NVIDIA
NVDA
|
+$143M |
| 5 |
Pfizer
PFE
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$242M |
| 2 |
First Solar
FSLR
|
+$153M |
| 3 |
Walmart Inc
WMT
|
+$133M |
| 4 |
Steel Dynamics
STLD
|
+$115M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.92% |
| 2 | Financials | 15.55% |
| 3 | Industrials | 13.68% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Healthcare | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Nuvation Bio
NUVB
$2.33B
| $69K | ﹤0.01% |
38,257
-225,486
| -85% | -$383K |
|
|
AFMD
3377
DELISTED
Affimed
AFMD
| $68K | ﹤0.01% |
11,370
-1,353
| -11% | -$10.8K |
|
3378
Anixa Biosciences
ANIX
$121M
| $67.8K | ﹤0.01% |
21,177
| – | – |
|
3379
Precigen
PGEN
$2.12B
| $67.3K | ﹤0.01% |
58,755
-13,405
| -19% | -$15.8K |
|
3380
Smart Sand
SND
$179M
| $67.1K | ﹤0.01% |
40,918
-114,776
| -74% | -$189K |
|
|
VXRT
3381
DELISTED
Vaxart
VXRT
| $66.5K | ﹤0.01% |
91,095
| – | – |
|
|
LUMO
3382
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $66.3K | ﹤0.01% |
20,089
| – | – |
|
3383
Sera Prognostics
SERA
$82.2M
| $65.6K | ﹤0.01% |
19,921
| – | – |
|
3384
Prelude Therapeutics
PRLD
$402M
| $63.6K | ﹤0.01% |
14,131
+1,372
| +11% | +$8.2K |
|
3385
Arts-Way Manufacturing Co
ARTW
$11.3M
| $63.6K | ﹤0.01% |
27,283
| – | – |
|
3386
Backblaze
BLZE
$758M
| $62.3K | ﹤0.01% |
+14,398
| New | +$62K |
|
3387
CytomX Therapeutics
CTMX
$714M
| $61.7K | ﹤0.01% |
35,865
-120,591
| -77% | -$200K |
|
|
HYPD
3388
Hyperion DeFi Inc
HYPD
$40.3M
| $60.1K | ﹤0.01% |
317
| – | – |
|
3389
CEL-SCI Corp
CVM
$21.3M
| $59.6K | ﹤0.01% |
825
-255
| -24% | -$18.6K |
|
3390
Absci
ABSI
$1.29B
| $59.6K | ﹤0.01% |
39,199
-7,641
| -16% | -$12.3K |
|
3391
Motorsport Games
MSGM
$19M
| $58.9K | ﹤0.01% |
14,081
-3,597
| -20% | -$17.8K |
|
|
ALP
3392
Alpha Compute
ALP
$4.68M
| $58.2K | ﹤0.01% |
851
| – | – |
|
3393
Bioventus
BVS
$893M
| $57.4K | ﹤0.01% |
19,858
-459
| -2% | -$881 |
|
3394
Lineage Cell Therapeutics
LCTX
$277M
| $57K | ﹤0.01% |
40,449
| – | – |
|
3395
Cosmos Holdings
COSM
$12.4M
| $56.5K | ﹤0.01% |
+18,881
| New | +$62.1K |
|
|
NVNO
3396
enVVeno Medical
NVNO
$7.1M
| $56.4K | ﹤0.01% |
523
-163
| -24% | -$21.2K |
|
|
CURO
3397
DELISTED
CURO Group Holdings Corp.
CURO
| $55.4K | ﹤0.01% |
41,069
-53,142
| -56% | -$81.4K |
|
3398
Lisata Therapeutics
LSTA
$9.38M
| $55.3K | ﹤0.01% |
14,951
| – | – |
|
|
WHLM
3399
DELISTED
Wilhelmina International, Inc
WHLM
| $54.9K | ﹤0.01% |
14,457
| – | – |
|
|
KZR
3400
DELISTED
Kezar Life Sciences
KZR
| $54.9K | ﹤0.01% |
2,240
-6,136
| -73% | -$160K |
|
Similar funds
Dimensional Fund Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Dimensional Fund Advisors held 3,572 positions worth $314B, up 5.7% from $297B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dimensional Fund Advisors's Q2 2023 filing shows 111 new, 1,840 increased, 1,366 reduced and 91 closed positions. Its largest new stake was Knife River: 1,268,239 shares worth $55.2M. The largest sale was Apple, an estimated $242M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2023 buy was Knife River: 1,268,239 shares worth $55.2M.
- Dimensional Fund Advisors added most to ExxonMobil in Q2 2023, an estimated $272M increase.
- Dimensional Fund Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $242M.
- Dimensional Fund Advisors fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $102M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $314B portfolio in Q2 2023.
- Dimensional Fund Advisors opened 111 new positions and closed 91 in Q2 2023.
- Dimensional Fund Advisors's portfolio value rose 5.7% quarter-over-quarter to $314B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.